CDMO RSI Chart
Last 7 days
7.0%
Last 30 days
-10.3%
Last 90 days
3.4%
Trailing 12 Months
-62.2%
Historical Charts for Stock Metrics
Year | Q1 | Q2 | Q3 | Q4 |
---|---|---|---|---|
2023 | 140.7M | 149.3M | 150.3M | 140.9M |
2022 | 116.0M | 119.6M | 125.5M | 134.2M |
2021 | 80.8M | 95.9M | 101.2M | 106.3M |
2020 | 64.2M | 59.7M | 69.8M | 72.6M |
2019 | 43.5M | 53.6M | 56.3M | 64.4M |
2018 | 64.6M | 53.6M | 39.1M | 36.5M |
2017 | 58.5M | 57.6M | 79.1M | 68.5M |
2016 | 35.2M | 44.7M | 40.6M | 54.5M |
2015 | 23.9M | 26.8M | 31.0M | 34.2M |
2014 | 20.2M | 22.4M | 23.2M | 22.2M |
2013 | 19.5M | 21.7M | 22.1M | 23.3M |
2012 | 15.9M | 15.2M | 13.8M | 15.7M |
2011 | 17.1M | 13.5M | 15.9M | 15.5M |
2010 | 0 | 27.9M | 24.3M | 20.7M |
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
Jan 12, 2024 | kwietniak matthew r. | sold | -1,854 | 6.77 | -274 | chief commercial officer |
Jan 11, 2024 | kwietniak matthew r. | acquired | - | - | 669 | chief commercial officer |
Jan 10, 2024 | richieri richard a. | sold | -6,509 | 6.17 | -1,055 | chief operations officer |
Jan 10, 2024 | hart daniel r | sold | -14,856 | 6.1697 | -2,408 | chief financial officer |
Jan 10, 2024 | kwietniak matthew r. | sold | -6,539 | 6.1698 | -1,060 | chief commercial officer |
Jan 10, 2024 | ziebell mark r | sold | -8,304 | 6.17 | -1,346 | v. p., general counsel |
Jan 10, 2024 | richieri richard a. | sold | -715 | 6.17 | -116 | chief operations officer |
Jan 09, 2024 | kwietniak matthew r. | acquired | - | - | 2,533 | chief commercial officer |
Jan 09, 2024 | ziebell mark r | acquired | - | - | 3,208 | v. p., general counsel |
Jan 09, 2024 | richieri richard a. | acquired | - | - | 2,512 | chief operations officer |
Which funds bought or sold CDMO recently?
View All DetailsDatesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
Mar 22, 2024 | PNC FINANCIAL SERVICES GROUP, INC. | reduced | -80.86 | -165,274 | 25,084 | -% |
Mar 11, 2024 | VANGUARD GROUP INC | reduced | -18.28 | -18,274,900 | 23,516,200 | -% |
Mar 08, 2024 | ICA Group Wealth Management, LLC | new | - | 13,559 | 13,559 | -% |
Mar 05, 2024 | Fisher Asset Management, LLC | unchanged | - | -670,497 | 1,482,390 | -% |
Mar 05, 2024 | GREENWOOD CAPITAL ASSOCIATES LLC | sold off | -100 | -294,415 | - | -% |
Mar 04, 2024 | VIMA LLC | new | - | 6,832 | 6,832 | 0.02% |
Mar 01, 2024 | GOLDMAN SACHS GROUP INC | added | 338 | 5,532,480 | 8,270,330 | -% |
Mar 01, 2024 | Pineridge Advisors LLC | new | - | 1,677 | 1,677 | -% |
Feb 28, 2024 | AMERICAN INTERNATIONAL GROUP, INC. | reduced | -9.48 | -121,171 | 200,506 | -% |
Feb 26, 2024 | TEACHERS RETIREMENT SYSTEM OF THE STATE OF KENTUCKY | reduced | -88.82 | -172,000 | 14,000 | -% |
Unveiling Avid Bioservices Inc's Major ShareHolders
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Stocks Marked 'Very Cheap' by Grufity's Fair Value Model Have Outperformed Russell 2000 Index
Small Caps and Mid Caps are mostly overlooked by investors as all the focus goes to Magnificent 7. These stocks that are not part of the beauty contest require a deeper look. However, all large cap stocks were once small caps. Grufity's Fair Value model opens up this unverse as it separates high-performing, rewarding stocks from low-performing risky stocks. <b>Russell 2000 stocks that were marked 'Very Cheap' by the model doubled in three years while the index was flat.</b>
Returns of $10,000 invested in:
Very Cheap Stocks: $21,859
Russell 2000 Index: $10,334
Very Expensive Stocks: $8,224
Russell 2000 stocks considered 'Very Cheap' by the model greatly outperformed Russell 2000 index and the 'Very Expensive' bucket over past three years.
Peers (Alternatives to Avid Bioservices Inc)
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
MRNA | 42.3B | 6.8B | -8.96 | 6.17 | ||||
HILS | 22.4B | 152.6K | -2.4K | 146.8K | ||||
ALNY | 19.4B | 1.8B | -44.17 | 10.64 | ||||
BMRN | 16.7B | 2.4B | 99.73 | 6.91 | ||||
INCY | 12.8B | 3.7B | 21.46 | 3.47 | ||||
MID-CAP | ||||||||
APLS | 7.1B | 396.6M | -13.34 | 17.78 | ||||
BBIO | 5.4B | - | -8.31 | 60.35 | ||||
AXSM | 3.8B | 270.6M | -15.68 | 13.86 | ||||
ARWR | 3.6B | 240.7M | -11.98 | 14.77 | ||||
ACAD | 3.0B | 726.4M | -48.93 | 4.13 | ||||
SMALL-CAP | ||||||||
CPRX | 1.9B | 398.2M | 26.85 | 4.82 | ||||
NVAX | 678.8M | 983.7M | -1.25 | 0.69 | ||||
CRBP | 373.2M | 881.7K | -8.37 | 466.16 | ||||
INO | 304.5M | 4.9M | -2.25 | 62.57 | ||||
IBIO | 11.8M | 2.1M | -0.43 | 2.14 |
Avid Bioservices Inc News
Income Statement (Quarterly) | ||||||||||||||||||||||
Description | (%) Q/Q | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 |
Revenue | -32.7% | 25,395 | 37,726 | 39,799 | 38,018 | 34,757 | 36,692 | 31,226 | 31,508 | 26,109 | 30,754 | 27,606 | 21,806 | 21,064 | 25,392 | 12,550 | 13,585 | 18,313 | 15,254 | 17,055 | 13,781 | 10,178 |
Cost Of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 12,800 | 14,953 | 14,168 | 13,407 | 11,731 | 9,844 |
Gross Profit | -213.8% | -4,665 | 4,100 | 8,391 | 9,825 | 4,147 | 9,117 | 6,984 | 9,087 | 9,186 | 11,391 | 8,143 | 6,202 | 6,418 | 8,544 | -1,299 | 785 | 3,360 | 1,086 | 3,648 | 2,050 | 334 |
Operating Expenses | 4.7% | 6,557 | 6,263 | - | 7,107 | 6,831 | 6,382 | - | 5,818 | 5,033 | 4,460 | - | 4,018 | 4,166 | - | - | 2,996 | 3,889 | - | - | 3,242 | 2,816 |
S&GA Expenses | 4.7% | 6,557 | 6,263 | 7,559 | 7,107 | 6,831 | 6,382 | 5,915 | 5,818 | 5,033 | 4,460 | 5,055 | 4,018 | 4,166 | 3,825 | 3,528 | 2,996 | 3,534 | 4,459 | 3,573 | 3,242 | 2,816 |
EBITDA Margin | -92.1% | 0.00* | 0.05* | 0.08* | 0.08* | 0.08* | 0.13* | 0.17* | 0.16* | 0.17* | 0.17* | 0.17* | -0.09* | - | - | - | - | - | - | - | - | - |
Interest Expenses | 3.9% | 805 | 775 | 759 | 620 | 703 | 518 | 555 | 718 | 704 | 703 | 1,160 | - | - | 4.00 | - | - | - | - | - | - | - |
Income Taxes | -305.1% | -2,378 | -587 | 757 | 2,069 | -2,086 | 703 | -115,011 | - | - | - | - | - | - | - | - | - | - | - | -67.00 | -44.00 | -173 |
Earnings Before Taxes | -343.5% | -11,887 | -2,680 | 448 | 2,530 | -3,242 | 2,267 | 587 | 2,248 | 3,522 | 6,304 | - | - | - | - | -4,768 | -2,104 | -430 | - | 167 | -1,183 | -2,363 |
EBT Margin | -319.8% | -0.08* | -0.02* | 0.01* | 0.02* | 0.01* | 0.07* | 0.11* | 0.10* | 0.11* | 0.11* | 0.12* | -0.13* | - | - | - | - | - | - | - | - | - |
Net Income | -354.3% | -9,509 | -2,093 | -309 | 461 | -1,156 | 1,564 | 115,598 | 2,248 | 3,522 | 6,304 | 1,991 | 2,207 | 2,284 | 4,730 | -4,768 | -2,104 | -430 | -3,164 | 336 | -1,139 | -1,451 |
Net Income Margin | -294.3% | -0.08* | -0.02* | 0.00* | 0.83* | 0.88* | 0.98* | 1.07* | 0.12* | 0.13* | 0.13* | 0.12* | 0.06* | - | - | - | - | - | - | - | - | - |
Free Cashflow | 91.5% | -1,224 | -14,392 | -22,078 | -18,244 | -38,245 | -11,958 | -23,954 | -14,829 | 2,978 | -11,141 | 13,713 | 2,452 | - | - | - | - | - | - | - | - | - |
Balance Sheet | ||||||||||||||||||||||
Description | (%) Q/Q | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 |
Assets | 2.8% | 455 | 442 | 451 | 450 | 442 | 451 | 430 | 314 | 302 | 271 | 266 | 168 | 114 | 106 | 108 | 105 | 105 | 102 | 78.00 | 76.00 | 80.00 |
Current Assets | 6.0% | 104 | 98.00 | 112 | 132 | 146 | 181 | 180 | 203 | 207 | 201 | 208 | 116 | 63.00 | 57.00 | 60.00 | 57.00 | 56.00 | 52.00 | 51.00 | 49.00 | 52.00 |
Cash Equivalents | 26.2% | 31.00 | 25.00 | 39.00 | 60.00 | 77.00 | 115 | 126 | 150 | 164 | 160 | 170 | 71.00 | 36.00 | 28.00 | 37.00 | 31.00 | 34.00 | 29.00 | 34.00 | 28.00 | 33.00 |
Inventory | -5.6% | 39.00 | 41.00 | 44.00 | 45.00 | 39.00 | 30.00 | 26.00 | 21.00 | 20.00 | 15.00 | 12.00 | 12.00 | 10.00 | 10.00 | 11.00 | 10.00 | 8.00 | 8.00 | 7.00 | 9.00 | 10.00 |
Net PPE | 2.7% | 187 | 182 | 177 | 164 | 139 | 115 | 93.00 | 69.00 | 52.00 | 45.00 | 37.00 | 32.00 | 30.00 | 28.00 | 27.00 | 27.00 | 27.00 | 26.00 | 26.00 | 26.00 | 26.00 |
Liabilities | 7.6% | 271 | 252 | 262 | 265 | 261 | 272 | 255 | 258 | 251 | - | 188 | 83.00 | 64.00 | 59.00 | 66.00 | 58.00 | - | - | 25.00 | - | - |
Current Liabilities | 20.1% | 77.00 | 64.00 | 74.00 | 87.00 | 82.00 | 93.00 | 76.00 | 77.00 | 70.00 | 63.00 | 71.00 | 63.00 | 44.00 | 38.00 | 44.00 | 37.00 | 34.00 | 29.00 | 23.00 | 21.00 | 23.00 |
Shareholder's Equity | -3.6% | 184 | 191 | 189 | 185 | 181 | 179 | 175 | 57.00 | 51.00 | 45.00 | 78.00 | 85.00 | 49.00 | 47.00 | 42.00 | 47.00 | 49.00 | 50.00 | 53.00 | 53.00 | 55.00 |
Retained Earnings | -2.2% | -442 | -432 | -430 | -430 | -430 | -429 | -431 | -546 | -549 | -552 | -559 | -561 | -564 | -566 | -571 | -566 | -564 | -563 | -560 | -560 | -559 |
Additional Paid-In Capital | 0.4% | 626 | 623 | 620 | 616 | 612 | 609 | 606 | 603 | 600 | 597 | 638 | 647 | 613 | 613 | 613 | 613 | 613 | 613 | 614 | 614 | 615 |
Shares Outstanding | 0.2% | 63.00 | 63.00 | 63.00 | 63.00 | 62.00 | 62.00 | 62.00 | 61.00 | 61.00 | 61.00 | 58.00 | 57.00 | - | - | - | - | - | - | - | - | - |
Float | - | - | - | - | - | 887 | - | - | - | 1,900 | - | - | - | 409 | - | - | - | 301 | - | - | - | 293 |
Cashflow (Quarterly) | ||||||||||||||||||||||
Description | (%) Q/Q | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 |
Cashflow From Operations | 2293.9% | 6,099 | -278 | 2,799 | -6,915 | -3,737 | -5,034 | 612 | 5,192 | 10,603 | -6,942 | 17,860 | 5,189 | 10,406 | -2,273 | 3,047 | -636 | 5,884 | -2,468 | 5,648 | -3,082 | -6,713 |
Share Based Compensation | 5.2% | 2,466 | 2,343 | 3,551 | 2,744 | 2,786 | 1,897 | 2,028 | 2,111 | 1,942 | 1,299 | 1,100 | 999 | 1,025 | 730 | 650 | 595 | 651 | 603 | 515 | 458 | 325 |
Cashflow From Investing | 48.1% | -7,323 | -14,114 | -24,877 | -11,329 | -34,508 | -6,924 | -24,566 | -20,021 | -7,625 | -4,199 | -4,147 | -2,737 | -2,491 | -489 | -787 | -2,040 | -947 | -38.00 | -208 | -802 | 2,746 |
Cashflow From Financing | 889.3% | 7,400 | 748 | 704 | 868 | 400 | 929 | 163 | 1,111 | 1,005 | 918 | 85,308 | 32,778 | -462 | -5,289 | 3,315 | -597 | -721 | -901 | -847 | -1,052 | -823 |
CONDENSED CONSOLIDATED STATEMENTS OF INCOME (LOSS) AND COMPREHENSIVE INCOME (LOSS) (Unaudited) - USD ($) shares in Thousands, $ in Thousands | 3 Months Ended | 6 Months Ended | ||
---|---|---|---|---|
Oct. 31, 2023 | Oct. 31, 2022 | Oct. 31, 2023 | Oct. 31, 2022 | |
Income Statement [Abstract] | ||||
Revenues | $ 25,395 | $ 34,757 | $ 63,121 | $ 71,449 |
Cost of revenues | 30,060 | 30,610 | 63,686 | 58,185 |
Gross profit (loss) | (4,665) | 4,147 | (565) | 13,264 |
Operating expenses: | ||||
Selling, general and administrative | 6,557 | 6,831 | 12,820 | 13,213 |
Total operating expenses | 6,557 | 6,831 | 12,820 | 13,213 |
Operating income (loss) | (11,222) | (2,684) | (13,385) | 51 |
Interest expense | (805) | (703) | (1,580) | (1,221) |
Other income, net | 140 | 145 | 398 | 195 |
Net loss before income taxes | (11,887) | (3,242) | (14,567) | (975) |
Income tax benefit | (2,378) | (2,086) | (2,965) | (1,383) |
Net income (loss) | (9,509) | (1,156) | (11,602) | 408 |
Comprehensive income (loss) | $ (9,509) | $ (1,156) | $ (11,602) | $ 408 |
Net income (loss) per share: | ||||
Basic | $ (0.15) | $ (0.02) | $ (0.18) | $ 0.01 |
Diluted | $ (0.15) | $ (0.02) | $ (0.18) | $ 0.01 |
Weighted average common shares outstanding: | ||||
Basic | 63,149 | 62,204 | 62,994 | 62,054 |
Diluted | 63,149 | 62,204 | 62,994 | 63,574 |
CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) - USD ($) $ in Thousands | Oct. 31, 2023 | Apr. 30, 2023 |
---|---|---|
Current assets: | ||
Cash and cash equivalents | $ 31,424 | $ 38,542 |
Accounts receivable, net | 13,379 | 18,298 |
Contract assets | 10,847 | 9,609 |
Inventory | 38,583 | 43,908 |
Prepaid expenses and other current assets | 9,972 | 2,094 |
Total current assets | 104,205 | 112,451 |
Property and equipment, net | 187,174 | 177,369 |
Operating lease right-of-use assets | 41,973 | 42,772 |
Deferred tax assets | 116,617 | 113,639 |
Other assets | 4,673 | 4,473 |
Restricted cash | 0 | 350 |
Total assets | 454,642 | 451,054 |
Current liabilities: | ||
Accounts payable | 22,784 | 24,593 |
Accrued compensation and benefits | 4,244 | 8,780 |
Contract liabilities | 46,437 | 37,352 |
Current portion of operating lease liabilities | 1,263 | 1,358 |
Other current liabilities | 2,209 | 1,626 |
Total current liabilities | 76,937 | 73,709 |
Convertible senior notes, net | 141,154 | 140,623 |
Operating lease liabilities, less current portion | 45,036 | 45,690 |
Finance lease liabilities, less current portion | 7,840 | 1,562 |
Total liabilities | 270,967 | 261,584 |
Commitments and contingencies | ||
Stockholders’ equity: | ||
Preferred stock, $0.001 par value; 5,000 shares authorized; no shares issued and outstanding at respective dates | 0 | 0 |
Common stock, $0.001 par value; 150,000 shares authorized; 63,234 and 62,692 shares issued and outstanding at respective dates | 63 | 63 |
Additional paid-in capital | 626,031 | 620,224 |
Accumulated deficit | (442,419) | (430,817) |
Total stockholders’ equity | 183,675 | 189,470 |
Total liabilities and stockholders’ equity | $ 454,642 | $ 451,054 |